Rhythm Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Rhythm Pharmaceuticals, Inc. (RYTM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-260.60-184.68-181.12-69.61-134.00-140.73-74.06
Depreciation & Amortization1.56-8.081.671.160.690.830.44
Stock Based Compensation39.6832.5519.8320.8017.460.000.00
Change in Working Capital10.584.62-17.411.90-5.904.130.67
Change in Accounts Receivable-3.65-8.64-5.20-1.250.000.000.00
Change in Inventory-10.12-5.71-2.81-0.010.000.000.00
Change in Accounts Payable21.9214.771.5418.31-6.450.000.00
Change in Other Working Capital2.4219.43-4.34-15.150.550.000.00
Other Operating Activities103.0751.984.87-100.2517.2211.884.51
Net Cash from Operating Activities-113.88-136.16-173.43-146.00-121.98-122.75-62.06
Investing Activities
Capital Expenditures0.00-0.05-0.28-0.430.213.39-0.72
Acquisitions0.000.000.007.000.000.000.00
Purchases of Investments-7.67-354.9232.31-163.73158.750.000.00
Sales/Maturities of Investments-40.50-354.92284.257.00158.75-24.59-86.43
Other Investing Activities-40.500.00-4.0095.000.000.000.00
Net Cash from Investing Activities-48.17-5.6728.03-62.16158.53-27.97-87.15
Financing Activities
Debt Repayment-12.900.000.000.000.000.000.00
Common Stock Issued56.3948.88141.49166.480.52161.91162.88
Dividends Paid-3.970.000.000.000.000.000.00
Other Financing Activities-4.0016.9772.340.000.000.000.00
Net Cash from Financing Activities191.2474.37213.83166.482.01163.47164.69
Summary
Effect of Forex Changes on Cash0.00-0.140.000.000.000.000.00
Net Change in Cash29.19-67.6068.43-41.6838.5612.7515.48
Cash at Beginning of Period60.41128.0159.58101.2662.7049.9434.46
Cash at End of Period89.60-491.08128.0159.5862.7061.5649.94
Free Cash Flow-113.88-136.16-173.71-146.44-122.19-126.14-62.78